Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ZBH

Are Medical Device Stocks Good Investments During a Recession?

The stock market has witnessed a massive sell-off lately on concerns over the Fed’s aggressive interest rate hikes to fight the decade-high inflation. Many analysts expect the economy to slip into recession due to the Fed’s monetary policy tightening. Since the medical device industry is known to be one of…

Analyst Ratings for Zimmer Biomet Holdings

Analyst Ratings for Zimmer Biomet Holdings

Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings:

Zimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates

Zimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates

Zimmer Biomet Holdings Inc's (NYSE:ZBH) Q1 sales increased by 3.9% Y/Y to $1.66 billion (up 6.8% on a constant currency basis), beating the consensus of $1.59 billion. Adjusted EPS was $1.61, which came in above the consensus of $1.41 and $1.55 a year ago. "We are encouraged by the better than expected results…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Zimmer Biomet: Q1 Earnings Insights

Zimmer Biomet Holdings (NYSE:ZBH) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Abbott Laboratories vs. Zimmer Biomet Holdings: Which Medical Device Stock is a Better Buy?

The medical devices industry is thriving and the integration of advanced technologies position the industry well for growth. Therefore, prominent players in this space, Abbott Laboratories (ABT) and Zimmer Biomet Holdings (ZBH), should benefit. But which of these stocks is a better buy now? Read more to find out.

Friday Is Your Last Chance To Buy Zimmer Biomet Holdings Before The Dividend Payout

Friday marks the last chance for investors to receive the next dividend payout from Zimmer Biomet Holdings (NYSE:ZBH).

Should You Scoop Up Shares of Zimmer Biomet Holdings on the Dip?

The shares of healthcare products and solutions provider Zimmer Biomet (ZBH) plunged in price after the company posted a dismal fourth-quarter earnings report. The company cited pandemic-induced challenges as having hampered its performance, while also anticipating these challenges will persist this year. So, will ZBH’s stock be able to gain…

inkl

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings For Zimmer Biomet Holdings

Analyst Ratings For Zimmer Biomet Holdings

Over the past 3 months, 10 analysts have published their opinion on Zimmer Biomet Holdings (NYSE:ZBH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Abbott Laboratories

Becton, Dickinson, and Company

Zimmer Biomet Holdings

Medical – Devices & Equipment

Zimmer Biomet Holdings Inc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Monetary Policy

Places

264,892 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play